Healthcare software provider Phreesia sets terms for $125 million IPO

Shutterstock photo

Phreesia, which provides a patient-intake software platform for healthcare providers, announced terms for its IPO on Monday.

The New York, NY-based company plans to raise $125 million by offering 7.8 million shares at a price range of $15 to $17. Insiders plan to sell on the overallotment . At the midpoint of the proposed range, Phreesia would command a fully diluted market value of $658 million. 

Phreesia was founded in 2005 and booked $104 million in sales for the 12 months ended April 30, 2019. It plans to list on the NYSE under the symbol PHR. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray are the joint bookrunners on the deal. It is expected to price during the week of July 15, 2019.

The article Healthcare software provider Phreesia sets terms for $125 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?